Grants per year
Personal profile
Research Interests
I am dedicated to providing the high-quality and compassionate care for patients with breast cancer. I am interested in clinical research with a focus on developing clinical trials of novel agents for the treatment of all stages of breast cancer and investigating biomarkers to guide therapy decisions.
Training Experience
2014 | Residency, Northwestern University, McGaw Medical Center |
2018 | Fellowship, Northwestern University, McGaw Medical Center |
Education/Academic qualification
MD, Northwestern University, Feinberg School of Medicine
… → 2011
Medicine, MD, Northwestern University, Feinberg School of Medicine
… → 2011
Fingerprint
- 7 Similar Profiles
Network
Grants
- 3 Active
-
Prot #SMX 18-001: An Open-label, Randomized, Multicenter Study Evaluating the Activity of Lasofoxifene Relative to Fulvestrant for the Treatment of Pre- and Postmenopausal Women with Locally Advanced or Metastatic ER+/HER2−Breast Cancer with an ESR1 Mutat
Linical Americas, Sermonix Pharmaceuticals, Inc.
5/28/20 → 5/28/23
Project: Research project
-
Prot #BTCRC-BRE18-337: Phase 2 Trial with Safety Run-In of Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers Big Ten Cancer Research Consortium BTCRC-BRE18-337
Hoosier Cancer Research Network, Inc., Pfizer Inc.
1/21/20 → 1/21/23
Project: Research project
-
Prot #ALT-002-SRE-01: A Phase I/II Dose Escalation Study of AP-002 In Patients with Advanced or Recurrent Solid Tumors
12/9/19 → 12/9/22
Project: Research project
Research Output
-
Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools
Gerratana, L., Davis, A. A., Polano, M., Zhang, Q., Shah, A. N., Lin, C., Basile, D., Toffoli, G., Wehbe, F., Puglisi, F., Behdad, A., Platanias, L. C., Gradishar, W. J. & Cristofanilli, M., Jan 2021, In: European Journal of Cancer. 143, p. 147-157 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Addressing Fertility: an Essential Aspect of Comprehensive Care for Young Patients with Breast Cancer
Shah, A. N., Luck, M., Goldman, K. & Gradishar, W., Dec 2020, In: Current Breast Cancer Reports. 12, 4, p. 381-390 10 p.Research output: Contribution to journal › Review article › peer-review
-
Hormone Receptor–Positive/Human Epidermal Growth Receptor 2–Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted Agents
Shah, A. N., Metzger, O., Bartlett, C. H., Liu, Y., Huang, X. & Cristofanilli, M., Jun 1 2020, In: Oncologist. 25, 6, p. e900-e908Research output: Contribution to journal › Review article › peer-review
Open Access -
Landscape of circulating tumour DNA in metastatic breast cancer
Davis, A. A., Jacob, S., Gerratana, L., Shah, A. N., Wehbe, F., Katam, N., Zhang, Q., Flaum, L., Siziopikou, K. P., Platanias, L. C., Gradishar, W. J., Behdad, A. & Cristofanilli, M., Aug 2020, In: EBioMedicine. 58, 102914.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Performance of a novel Next Generation Sequencing circulating tumor DNA (ctDNA) platform for the evaluation of samples from patients with metastatic breast cancer (MBC)
Gerratana, L., Zhang, Q., Shah, A. N., Davis, A. A., Zhang, Y., Wehbe, F., Qiang, W., Flaum, L., Finkelman, B. S., Gradishar, W. J., Platanias, L. C., Behdad, A. & Cristofanilli, M., Jan 2020, In: Critical Reviews in Oncology/Hematology. 145, 102856.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations